Industrial Biomanufacturing

Futurized - thought leadership on the future - En podcast af Trond Arne Undheim

Our guest today, is Moji Karimi, CEO & co-founder, Cemvita Factory. In episode 126 of the Futurized podcast (@futurized2), hosted by futurist Trond Arne Undheim (@trondau), the topic is: Industrial Biomanufacturing. In this conversation, they talk about the challenges of scaling up industrial biomanufacturing, operational challenges, the emerging business models, and the technical challenges, and the future outlook. If you're new to the show, seek particular topics, or you are looking for a great way to tell your friends about the show, which we always appreciate, we've got the episode categories. Those are at Futurized.org/episodes. They are collections of your favorite episodes organized by topic, such as Entrepreneurship, Trends, Emerging Tech, or The Future of Work. That'll help new listeners get a taste of everything that we do here, starting with a topic they are familiar with, or want to go deeper in. The host of this podcast, Trond Arne Undheim, Ph.D is the author of Health Tech: Rebooting Society's Software, Hardware and Mindset--published by Routledge in 2021, Future Tech: How to Capture Value from Disruptive industry Trends--published by Kogan Page in 2021, Pandemic Aftermath: how Coronavirus changes Global Society and Disruption Games: How to Thrive on Serial Failure (2020)--both published by Atmosphere Press in 2020, Leadership From Below: How the Internet Generation Redefines the Workplace by Lulu Press in 2008. For an overview, go to Trond's Books at Trondundheim.com/books At this stage, Futurized is lucky enough to have several sponsors. To check them out, go to Sponsors | Futurized - thoughts on our emerging future. If you are interested in sponsoring the podcast, or to get an overview of other services provided by the host of this podcast, including how to book him for keynote speeches, please go to Store | Futurized - thoughts on our emerging future. We will consider all brands that have a demonstrably positive contribution to the future. Trond's takeaway Industrializing microbes is both fascinating and scary. Can biology truly be put under human control to fix our energy challenges, reduce emissions, and put us towards the path of regenerative economic growth? Time will show, but startups such as Cemvita are making headway. There is no question of the need for industrial biomanufacturing as a novel approach. Surprisingly, what seems to be the biggest challenge isn't the deep science itself, but the operational challenges in scaling the technology properly so that the promising use cases can materialize in synch with market expectations. Thanks for listening. If you liked the show, subscribe at Futurized.org or in your preferred podcast player, and rate us with five stars. If you like this topic, you may enjoy other episodes of Futurized, such as episode 120, Regenerative Medicine, episode 90, Upskilling Youth for the 21st Century Bioeconomy, or episode 123, Regenerative Business. Hopefully, you'll find something awesome in these or other episodes. If so, do let us know by messaging us, we would love to share your thoughts with other listeners. Futurized is created in association with Yegii, the insight network. Yegii lets clients create multidisciplinary dream teams consisting of a subject matter experts, academics, consultants, data scientists, and generalists as team leaders. Yegii's services include speeches, briefings, seminars, reports and ongoing monitoring. You can find Yegii at Yegii.org. Please share this show with those you care about. To find us on social media is easy, we are Futurized on LinkedIn and YouTube and Futurized2 on Instagram and Twitter: Instagram: https://www.instagram.com/futurized2/ Twitter (@Futurized2): https://twitter.com/Futurized2 Facebook: https://www.facebook.com/Futurized-102998138625787 LinkedIn: https://www.linkedin.com/company/futurized YouTube: https://www.youtube.com/Futurized Podcast RSS: https://feed.podbean.com/www.futurized.co/feed.xml See you next tim

Visit the podcast's native language site